Marysol Valencia Buitrago

Dr. Marysol Valencia Buitrago

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
CGCarlos Naranjo Galvis
Carlos Naranjo Galvis
DTDiana Trejos-Gallego
Diana Trejos-Gallego
CCCristina Correa-Salazar
Cristina Correa-Salazar
JTJessica Triviño-Valencia
Jessica Triviño-Valencia
MBMarysol Valencia Buitrago
Marysol Valencia Buitrago
LSLuisa Matilde Salamanca-Duque
Luisa Matilde Salamanca-Duque
Background/Objectives: Autism spectrum disorder (ASD) is a neurodevelopmental condition associated with behavioral and cognitive impairments. Increasing evidence also links ASD with systemic immune dysregulation, including abnormal cytokine profiles and chronic low-grade inflammation. Emerging evidence suggests that targeted dietary strategies and probiotic supplementation may modulate immune responses and gut–brain interactions in patients with ASD. This study aimed to evaluate the immunomodulatory effects of a structured anti-inflammatory diet (NeuroGutPlus) compared to multi-strain probiotics in children with ASD. NeuroGutPlus is a nutritionally complete anti-inflammatory dietary protocol that targets gut integrity, inflammation, and mitochondrial function. It includes a diet low in gluten, FODMAPs, casein, and artificial additives, and a high intake of omega-3 fatty acids, polyphenols, and fermentable fibers. Methods: A total of 30 children with ASD and 12 neurotypical controls were enrolled in a 12-week randomized controlled nutritional trial. Participants received either a NeuroGutPlus anti-inflammatory diet, probiotic supplementation (16 strains of Lactobacillus and Bifidobacterium), or no intervention. Plasma levels of 20 cytokines and chemokines were measured pre- and post-intervention using multiplex Luminex immunoassays. Principal component analysis (PCA) was used to explore shifts in the immune profile. Results: Patients treated with the NeuroGutPlus diet significantly reduced IFN-γ levels (p = 0.0090) and showed a stabilizing effect on immune profiles, as evidenced by PCA clustering. Probiotic supplementation led to a significant increase in IL-8 (+66.6 pg/mL; p = 0.0350) and MIP-1β (+74.5 pg/mL; p = 0.0100), along with a decrease in IFN-γ (p = 0.0070), suggesting reconfiguration of innate immune responses. Eight out of eleven biomarkers showed significant post-intervention differences between groups, indicating distinct immunological effects. Conclusions: This study provides evidence that anti-inflammatory diets exert broader and more consistent immunoregulatory effects than probiotics alone in children with ASD. These findings support the inclusion of precision dietary strategies as non-pharmacological interventions to mitigate immune-related dysfunction in patients with ASD.

15 September 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
MBMarysol Valencia Buitrago
Marysol Valencia Buitrago
RCRodrigo Carvalho
Rodrigo Carvalho
VCValbert Cardoso
Valbert Cardoso
JTJessica Triviño-Valencia
Jessica Triviño-Valencia
LSLuisa Matilde Salamanca-Duque
Luisa Matilde Salamanca-Duque
CGCarlos Naranjo Galvis
Carlos Naranjo Galvis
Background: Autism Spectrum Disorder (ASD) is increasingly associated with alterations in gut microbiota, intestinal permeability, and immune dysregulation. However, integrative studies exploring these mechanisms in Latin American populations are lacking. Objective: To characterize gut microbiota profiles in Colombian children with ASD and evaluate the effects of two microbiota-targeted interventions, an anti-inflammatory diet and a probiotic formulation, on microbial diversity and taxonomic composition. Methods: In a two-phase study, shotgun metagenomic sequencing was performed on fecal samples from 23 children with ASD and 7 typically developing (TD) controls. In the second phase, 17 children with ASD were randomized to receive a 12-week intervention (anti-inflammatory diet, probiotics, or no intervention). Alpha diversity indices (Shannon, Pielou, and Chao1) and differential abundance analyses were conducted. Results: Compared to TD children, those with ASD showed a higher Firmicutes/Bacteroidetes ratio and a significantly increased abundance of genera such as Clostridioides, Thomasclavelia, Alistipes, and Coprococcus. The presence of functional gastrointestinal disorders (FGIDs) in ASD patients is associated with reduced microbial richness. POST-intervention, the anti-inflammatory diet group showed that no statistically significant changes in alpha diversity were observed, although a slight upward trend was noted and significant enrichment of six bacterial genera, including Moraxella and Eubacterium. The probiotic group exhibited a significant increase in Romboutsia and a decrease in Lachnospira. Cytokine–microbiota networks in ASD were fragmented and dominated by IFN-γ and MCP-1 hubs, indicating systemic immune activation. Interventions induced functional remodeling: The anti-inflammatory diet increased the number of beneficial genera (Eubacterium, Adlercreutzia) and shifted networks toward positive correlations involving IL-8 and MIP-1β. Probiotics increased Romboutsia, reduced Lachnospira, and restructured networks with regulatory cytokines (SDF-1α, Eotaxin) and SCFA-producing taxa (Blautia, Roseburia). Conclusions: Children with ASD in Colombia displayed distinct microbial profiles characterized by pro-inflammatory taxa and altered richness. Both the anti-inflammatory diet and probiotics produced compositional shifts in the gut microbiota, although global changes in diversity were limited. These findings support the potential of microbiota-targeted nutritional strategies for ASD and underscore the need for precision interventions tailored to specific clinical and microbial phenotypes.

1 January 2026 in Retos
Verified
Journal Article
Open access
PDF file
LSLuisa Matilde Salamanca-Duque
Luisa Matilde Salamanca-Duque
DGDiana María Trejos Gallego
Diana María Trejos Gallego
JVJessica Triviño Valencia
Jessica Triviño Valencia
MBMarysol Valencia Buitrago
Marysol Valencia Buitrago
MMMiguel Andres Meñaca-Puentes
Miguel Andres Meñaca-Puentes
CGCarlos Naranjo Galvis
Carlos Naranjo Galvis
Introduction: Autism Spectrum Disorder (ASD) is characterized by multiple difficulties in psychomotor development that affect the performance of daily activities and social participation. Several studies have suggested that diet and the balance of the gut microbiota can positively influence the neurodevelopment and functioning characteristics of people with ASD. Objetive: This study explores the effect of an anti-inflammatory diet on psychomotor profiles of children with ASD. Methodology: A quasi-experimental study was conducted with 18 children diagnosed with ASD: 9 in the experimental group and 9 in the control group, and 12 neurotypical children: 6 in the experimental group and 6 in the control group. Patients were evaluated before and after a 12-week anti-inflammatory nutritional intervention. Sociodemographic and clinical characteristics, nutritional status, muscle tone, balance, laterality, spatiotemporal structuring, body notion, global praxia, fine praxia, and psychomotor profile were evaluated. Results: There were significant improvements (p0.8), indicating substantial changes owing to the intervention. Discussion: These findings support the integration of nutritional interventions into interdisciplinary therapeutic programs in clinical and educational contexts. However, further robust studies are required to confirm this. Conclusions: Implementation of an anti-inflammatory diet can improve the psychomotor profile of children with ASD.

20 April 2020
Verified
Book
Open access
PDF file
Leidy Tatiana Ordoñez-MoraLeidy Tatiana Ordoñez-Mora
Leidy Tatiana Ordoñez-Mora
DSDiana Patricia Sánchez
Diana Patricia Sánchez
UCUniversidad Santiago de Cali
Universidad Santiago de Cali
JDJorge Enrique Daza-Arana
Jorge Enrique Daza-Arana
LTLina Johanna Álvarez Toro
Lina Johanna Álvarez Toro
SCSandra Milena Carabalí Cachimbo
Sandra Milena Carabalí Cachimbo
Este libro pretende abordar la importancia de realizar procesos evaluativos, que permitan una correlación y análisis clínico considerando la perspectiva del movimiento corporal humano, a partir del examen y la evaluación. Por tanto, una adecuada valoración de la función neuromuscular garantiza la adecuada interacción como elemento inicial planificador y efector del movimiento a diferentes niveles, permitiendo un adecuado diseño y ejecución de programas de rehabilitación neuromuscular, disminución del riesgo de lesiones y el paso a las actividades de la vida diaria y ocupacionales.

1 July 2018 in Rehabilitación
Verified
Journal Article
Closed access
MBMarysol Valencia Buitrago
Marysol Valencia Buitrago
ADA. Duque-Alzate
A. Duque-Alzate
MPMonica Yamile Pinzon
Monica Yamile Pinzon
JCJ. Castellanos-Ruiz
J. Castellanos-Ruiz

26 December 2025 in Medical Sciences
Verified
Journal Article
Open access
PDF file
LRLuisa Fernanda Méndez Ramírez
Luisa Fernanda Méndez Ramírez
MMMiguel Andres Meñaca-Puentes
Miguel Andres Meñaca-Puentes
LSLuisa Matilde Salamanca-Duque
Luisa Matilde Salamanca-Duque
MBMarysol Valencia Buitrago
Marysol Valencia Buitrago
ARAndrés Felipe Ruiz-Pulecio
Andrés Felipe Ruiz-Pulecio
CGCarlos Naranjo Galvis
Carlos Naranjo Galvis
Background/Objective: Neuroimmune and metabolic dysregulation have been increasingly implicated in the cognitive heterogeneity of autism spectrum disorder (ASD). However, it remains unclear whether anti-inflammatory diets engage distinct biological and cognitive pathways in autistic and neurotypical children. This study examined whether a 12-week anti-inflammatory dietary protocol produces group-specific neuroimmune–metabolic signatures and cognitive responses in autistic children, neurotypical children receiving the same diet, and untreated neurotypical controls. Methods: Twenty-two children (11 with ASD, six a on neurotypical diet [NT-diet], and five neurotypical controls [NT-control]) completed pre–post assessments of plasma IFN-γ, CXCL1, RANTES (CCL5), trimethylamine-N-oxide (TMAO), and an extensive ENI-2/WISC-IV neuropsychological battery. Linear mixed-effects models were used to test the Time × Group effects on biomarkers and cognitive domains, adjusting for age, sex, and baseline TMAO. Bayesian estimation quantified individual changes (posterior means, 95% credible intervals, and posterior probabilities). Immune–cognitive coupling was explored using Δ–Δ correlation matrices, network metrics (node strength, degree centrality), exploratory mediation models, and responder (≥0.5 SD domain improvement) versus non-responder analyses. Results: In ASD, the diet induced robust reductions in IFN-γ, RANTES, CXCL1, and TMAO, with decisive Bayesian evidence for IFN-γ and RANTES suppression (posterior P(δ < 0) > 0.99). These shifts were selectively associated with gains in verbal learning, semantic fluency, verbal reasoning, attention, and visuoconstructive abilities, whereas working memory and executive flexibility changes were heterogeneous, revealing executive vulnerability in individuals with smaller TMAO reductions. NT-diet children showed modest but consistent improvements in visuospatial processing, attention, and processing speed, with minimal biomarker changes; NT controls remained biologically and cognitively stable. Network analyses in ASD revealed a dense chemokine-anchored architecture with CXCL1 and RANTES as central hubs linking biomarker reductions to improvements in fluency, memory, attention, and executive flexibility. ΔTMAO predicted changes in executive flexibility only in ASD (explaining >50% of the variance), functioning as a metabolic node of executive susceptibility. Responders displayed larger coordinated decreases in all biomarkers and broader cognitive gains compared to non-responders. Conclusions: A structured anti-inflammatory diet elicits an ASD-specific, coordinated neuroimmune–metabolic response in which suppression of CXCL1 and RANTES and modulation of TMAO are tightly coupled with selective improvements in verbal, attentional, and executive domains. Neurotypical children exhibit modest metabolism-linked cognitive benefits and minimal immune modulation. These findings support a precision-nutrition framework in ASD, emphasizing baseline immunometabolic profiling and network-level biomarkers (CXCL1, RANTES, TMAO) to stratify responders and design combinatorial interventions targeting neuroimmune–metabolic pathways.